Torrent Pharmaceuticals · NSE: TORNTPHARM · BSE: 500420
Q1 FY19 results · Apr–Jun 2018
Torrent Pharmaceuticals reported revenue from operations of ₹1,872.00 crore and net profit of ₹163.00 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,872.00 | — | — | — | — |
| Other income | 27.00 | — | — | — | — |
| Total income | 1,899.00 | — | — | — | — |
| Profit before tax | 232.00 | — | — | — | — |
| Net profit for the period | 163.00 | — | — | — | — |
| EPS, basic (₹) | 9.66 | — | — | — | — |
| Net margin (%) | 8.7 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,452.00 | — | — | — | — |
| Other income | 34.00 | — | — | — | — |
| Total income | 1,486.00 | — | — | — | — |
| Profit before tax | 188.00 | — | — | — | — |
| Net profit for the period | 122.00 | — | — | — | — |
| EPS, basic (₹) | 7.21 | — | — | — | — |
| Net margin (%) | 8.4 | — | — |
Consolidated
- Filed with BSE
- 03 Aug 2018, 11:23 IST
- Board meeting
- 02 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 03 Aug 2018, 11:23 IST
- Board meeting
- 02 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Audited
- Source
- XBRL filing on BSE